Who should receive combination therapy for ER positive breast cancer?
12 Oct 2016
Who should receive combination therapy for ER positive breast cancer?
Drug repurposing of propranolol
Caring for lung cancer patients
Diet, transplacental carcinogenesis and risk to children: results from the NewGeneris project
DNA methylation as a mediator of in utero exposures on the risk of childhood ALL
How to avoid false positives in lung cancer
Drug repurposing in review
Tumour metabolism in chemoprevention
Bring patient voices into research
Patient advocacy in breast cancer research
Food, diet and prostate cancer
Societal barriers to chemoprevention